ABSTRACT
INTRODUCTION
Cardiovascular disease is the most common cause of mortality and morbidity in the United States and many other nations (Reddy-Vanga et al. 2010) . Coronary atherosclerosis process is multi-factorial. Traditional and classic cardiovascular risk factors such as diabetes mellitus (DM), hypertension (HTN), smoking and obesity have introduced as major causes, but significant proportions of the patients with coronary artery disease (CAD) do not have these traditional risks. Other factors, which may affect this chronic process, have been evaluated (Folsom et al. 1998; Reddy-Vanga et al. 2010; Rogha et al. 2012) . For example, infectionrelated chronic inflammation from Helicobacter pylori (H. pylori) is one of the CAD risk factors, because the CAD risk factors plasma fibrinogen, C-reactive protein, and blood leukocyte count become elevated in the seropositive subjects (Folsom et al. 1998) . H. pylori infection is the most common infection worldwide, especially in the developing countries (Rogha et al. 2012 ). According to many reports, 70-90% of apparently healthy people of developing countries are estimated to be infected with H. pylori (Rogha et al. 2012; Chmiela et al. 2015; Javadi et al. 2015) . H. pylori is a Gram-negative bacterium with perfect adaptation to the acidic environment of the stomach and high affinity to gastric epithelial cells. Recently, possible association between H. pylori infection and extragastric disorders has been also suggested (Franceschi et al. 2006; Pacifico et al. 2010; Pacifico et al. 2014 ). An indirect association between the prevalence of H. pylori and the occurrence of CAD is demonstrated by many research studies (Rogha et al. 2012; Chmiela et al. 2015; Javadi et al. 2015) . A significant association of H. pylori infection with CAD (OR 3.18, 95% CI 1.08-9.40) was shown by a multivariate logistic regression analysis (Rogha et al. 2012) . According to majority of findings, the involvement of H. pylori in this process was based on the chronic inflammation, which might facilitate the CAD-related pathologies (Rogha et al. 2012; Chmiela et al. 2015) . Several mechanisms have been proposed for how H. pylori might accelerate macrovascular complications and increase CAD risk (Cenerelli et al. 2002; Rogha et al. 2012; Javadi et al. 2015) . It has been demonstrated that H. pylori is an important and serious cause of elevated levels of homocysteine (HCY) and is prevalent in the Caucasian population, ranging from 30 to 40% incidence. On the other hand, HCY is recognized as an independent risk factor for cardiovascular diseases. HCY has been demonstrated to be toxic to the endothelial cells and lipoproteins due to generation of oxygen radicals. High level of HCY appears to be one of the factors responsible for the increased risk of vascular damage and clinical CAD events (Sacco et al. 2004) . A study on 116 patients with CAD who were matched with 116 controls via age and sex although showed a minor association between H. pylori infection and CAD. However, a stronger correlation between higher levels of triglycerides (fats) and lower levels of high density high-density lipoprotein (HDL) -cholesterol was found in the H. pylori-infected patients (Laurila et al. 1999; Ekesbo et al. 2000; Hoffmeister et al. 2001; Kowalski 2001) . Based on the above findings, these results could be consistent with the hypothesis that H. pylori infection might modify the serum lipid concentrations in a way that could increase the risk of CAD (Sacco et al. 2004) . Hence, knowing the inflammation as a cardiovascular risk factor in the one hand and H. pylori and hyperhomocysteinemia involvement in CAD incidence on the other hand could be interesting to evaluate the H. pylori infection effect on HCY levels and atherosclerosis processes. Thus, this study examined whether H. pylori seropositivity was associated with hyperhomocysteinemia and cardiovascular disease occurrence.
MATERIAL AND METHODS

Sampling and Coronary Angiography
This study was approved by the Ethical Committee of Iran University of Medical Sciences. The crosssectional study was performed in Rasool Akram Hospital of Tehran from June 2014 to October 2014. Ninety six consecutive CAD patients (68 men and 28 women; mean age 52. 95 ± 1.25 and 51.32 ± 1.61 years old, respectively) and 64 controls were enrolled into the study and candidates for coronary angiography and informed consent were selected. Before catheterization, all the subjects completed a semi-structured questionnaire regarding their past medical and drug history. The diagnosis was based on the decision of an experienced clinician. Coronary angiography was carried out by left-heart catheterization and arteriography using Judkins method, and then a cardiologist separately reviewed the angiography films. According to angiography reports, the clinical and laboratory evaluated patients with ≥50% coronary stenosis were considered as CAD positive group and participants with <50% coronary stenosis were considered as CAD negative group, or controls. Accordingly, patients with hepatic dysfunction, autoimmune disease, thyroid dysfunction and/or adrenal dysfunction as well as patients who consumed any kinds of glucocorticoids were excluded from the study.
Biochemical Measurements
Fasting blood sample of catheterization participants were taken to measure lipid profiles, immunoglobulins G and A (anti H. pylori IgG and IgA) and homocysteine levels.
ELISA kit (Diagnostic kit, PISHTAZ TEB Company, Teheran, Iran) was used to measure the homocysteine levels. Anti-H. pylori antibody status was determined by measuring the IgG and IgA antibody by ELISA assay (Diagnostic kit, PISHTAZ TEB Company). Spectrophotometric assay was used for lipid profiles assay.
Statistical Data Analysis
Statistical analyses were carried out using SPSS software (version 16.0, Chicago, IL, USA). Unpaired student t-tests and ANOVA test were used for comparing the continuous variable. Chisquare test was used for discrete variables. To compare the association of H. pylori infection with homocysteine and thereby CAD, logistic regression tests were used by adjusting the sex and age plus history of diabetes, dyslipidemia, and/or hypertension.
RESULTS
Demographic characteristics of four study groups are shown in Tables 1 and 2 . No significant differences were found in terms of demographic characteristics between the CAD patients and controls with anti-H. pylori IgG positive and negative and between the CAD patients and controls with anti-H. pylori IgA positive and negative. As shown in Table 1 , the anti-H. pylori IgG (72.49 ± 3.64U/mL) and IgA (46.72 ± 3.24 U/mL) levels of CAD patient with positive anti -H. pylori IgG were significantly more than those were found in the CAD patients with negative anti-H. pylori IgG (9.34 ± 2.11 and 12.20 ± 1.15 U/mL). The values of 8.05 ± 0.40 and 15.48 ± 3.18 U/mL were achieved for anti-H. pylori IgG and anti-H. pylori IgA of controls with negative anti-H.P. IgG, respectively, which were lower significantly than those found for CAD patient with positive and negative anti-H. pylori IgG. The anti-H. pylori IgG (67.21 ± 4.00 U/mL) and anti-H. pylori IgA (38.90 ± 3.68 U/mL) levels of the control group with positive anti-H. pylori IgG were lower than CAD patient with positive anti-H. pylori IgG but significantly higher than negative anti-H. pylori IgG CAD patients. (Fig.1 B) , while the correlation between the anti-H. pylori IgG and homocysteine levels of CAD patients with negative anti-H. pylori IgG was not significant (r= 0.005, P=0.493). The correlation between the anti-H. pylori IgG and homocysteine levels of the control group with positive and negative anti-H.P IgG was not significant (r= -0.071, P=0.325 and r= -0.071, P=0.325, respectively). It is worth to note that correlation between the anti-H. pylori IgG and homocysteine levels of all the subjects was significant (r= 0.233, P=0.002). (Fig. 3) . 
DISCUSSION
Several studies have demonstrated that hyperhomocysteinemia and H. pylori infection have contributed in the cardiovascular disease pathogenesis, independent of other conventional risk factors (Sung and Sanderson 1996; Leung et al. 2001; Sharma and Aggarwal 2015) . As shown in Tables 1 and 2 , there was not a significant difference between the demographic characterization of the patients with CAD and controls. According to Figures 1 A and 2 A, a significant difference was found between anti-H.P. IgG and IgA levels of the patients with CAD (P= 0.020) and controls (P=0.011). Serum homocysteine concentration of the patients with CAD was more than the controls significantly. A positive correlation was found between the homocysteine levels and anti-H. pylori IgG in the patients with CAD as comparison to the control subjects. It has been proposed that H. pylori infection might modify the serum homocysteine concentration in a way that could increase the risk of CAD. The results of a case-control study showed that H. pylori infection increased a twofold risk of CAD (Sung and Sanderson 1996) . However, the possible mechanism of a chronic infection by H. pylori leading to atherosclerosis is yet to be identified. One of the proposed mechanisms is that H. pylori chronic infection increases the acute inflammation factors such as fibrinogen and sialic acid, which are predictors of CAD (Ringnér et al. 1994) . In consistent with these results, a higher concentration of fibrinogen and total leukocyte count were reported for the patients with cardiovascular disease and infected by H. pylori as comparison to controls (Patel et al. 1995) . The other hypothesis is that chronic H. pylori infection leads to malabsorption of vitamin B-6, vitamin B-12 and folate, methylation defeat and hyperhomocysteinaemia, thereby inducing arterial damage. It has been shown that nitric oxide secretion from the endothelial cells is inhibited by homocysteine, which comforts platelet aggregation and vasoconstriction. The balance between the procoagulants and anticoagulants might be changed by homocysteine via selective manners such as inhibition of the thrombomodulin processing and releasing, decreasing the protein C activation and inducing a protease activator of coagulation factor V (Sung and Sanderson 1996) . Other mechanisms of H. pylori infection that could lead to atherosclerosis are destructive influence of H. pylori and its products like cytokines and cytotoxins on coronary endothelium, activation of immune mechanisms, which react with the nuclei of monocytes in atherosclerotic vessel wall and cytoplasm of fibroblast-like cell in atherosclerosis plaques (Rogha et al. 2012) . In agreement with the present results, the results of a study on 93 patients under diagnostic coronary arteriography with infection H. pylori, showed a significant decrease of vitamin B12 and folate levels, thereby increasing homocysteine levels. They suggested that homocysteine could induce endothelial damage directly, affect platelet function and coagulation factors and increase the oxidation of LDL-C, which have critical role in cardiovascular disease occurrence (Ringnér et al. 1994) . In a study patients with H. pylori infection exhibited a decreased secretion of ascorbic acid by gastric mucosa and elevated gastric pH, thereby the folate absorption from the diet was decreased due to low ascorbic acid in gastric juice, and subsequently a significant rise was found in homocysteine levels (Lucock et al. 1995) . However, it is important to consider that confounding variables such as vitamin deficiency, acute-phase response to vascular diseases, medication use, hypertension, advanced age and gender are well-known factors influencing homocysteinemia and should be considered. An inverse relationship was demonstrated among the homocysteine levels and H. pylori infection in the patients with functional dyspepsia in a cross-sectional study by Rasool et al. (2012) . The authors showed that 46.2% of H. pyloripositive patients had hyperhomocysteinemia (>15 μmol/L) when compared to H. pylori-negative group (44%). They also reported that this was a higher proportion in comparison with that was observed in healthy population (Rasool et al. 2012 ). The results demonstrated that H. pylori did affect directly HCY metabolism in the liver (Cenerelli et al. 2002; Longo-Mbenza et al. 2012) . They showed that disrupted metabolism of HCY, which was induced by H. pylori led to an increase of HCY levels similar to those found in diabetic patients. Emphasizing the probable impairment of insulin function regarding the regulation of HCY level through the homocysteine/methionine metabolism, which caused higher levels of HCY in the CAD patients infected by H. pylori and the importance of H. pylori infection in determining the elevated HCY levels.
In summary, a small sample size was investigated and these observations should be confirmed in a larger sample of the patients with more analysis works. Here, only two independent variables were analysed, but it would be worthwhile to consider other probable variables involving in CAD disease in future studies.
CONCLUSION
The present study demonstrated an inverse relationship between the homocysteine levels and H. pylori seropositivity (IgG and IgA) and atherosclerosis occurrence in the patients with CAD. Since classic risk factors were not able to explain all cases of CAD, the results of present study suggested that chronic H. pylori infection affected the development or maintenance of CAD, since it induced chronic long term infection within gastric epithelium, which led to not only local but systemic inflammation. According to the present findings, the involvement of H. pylori in this process was based on the chronic inflammation, which might facilitate the CAD-related pathologies. Moreover, impact of the presence of H. pylori was found on homocysteine levels in such patients.
